A MULTICENTER, RANDOMIZED, DOUBLE-MASKED, SHAM-CONTROLLED, PARALLEL-GROUP PHASE 3 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF EPITHELIUM-ON CORNEAL CROSS-LINKING IN SUBJECTS 8 TO 45 YEARS OF AGE WITH KERATOCONUS (APRICITY-B)
Description
To evaluate the efficacy of the riboflavin-sodium iodide solution followed by ultraviolet A (UVA) exposure and epithelium-on corneal crosslinking (CXL) assessed by visual acuity measurement in subjects with keratoconus.
Details
Age
Child to Adult
Eligibility
Males and females ≥ 8 to ≤ 45 years of age with the clinical diagnosis of keratoconus. Diagnosis will be confirmed by tomographic imaging
Type of Study
Treatment
Locations
University of Colorado Hospital
Principal Investigator
Michael Taravella, MD
Study ID
Protocol Number: 23-1425
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers